157 related articles for article (PubMed ID: 19003600)
1. Variability and function of family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A).
Strassburg CP; Kalthoff S; Ehmer U
Crit Rev Clin Lab Sci; 2008; 45(6):485-530. PubMed ID: 19003600
[TBL] [Abstract][Full Text] [Related]
2. Family 1 uridine-5'-diphosphate glucuronosyltransferases (UGT1A): from Gilbert's syndrome to genetic organization and variability.
Strassburg CP; Lankisch TO; Manns MP; Ehmer U
Arch Toxicol; 2008 Jul; 82(7):415-33. PubMed ID: 18491077
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of Gilbert's syndrome.
Strassburg CP
Pharmacogenomics; 2008 Jun; 9(6):703-15. PubMed ID: 18518849
[TBL] [Abstract][Full Text] [Related]
4. Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Tukey RH; Strassburg CP
Annu Rev Pharmacol Toxicol; 2000; 40():581-616. PubMed ID: 10836148
[TBL] [Abstract][Full Text] [Related]
5. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype.
Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP
Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217
[TBL] [Abstract][Full Text] [Related]
6. Gilbert-Meulengracht's syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?
Strassburg CP
Drug Metab Rev; 2010 Feb; 42(1):168-81. PubMed ID: 20070246
[TBL] [Abstract][Full Text] [Related]
7. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
[TBL] [Abstract][Full Text] [Related]
9. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment.
Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP
J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of the baboon UDP-glucuronosyltransferase 1A gene family: evolution of the primate UGT1 locus and relevance for models of human drug metabolism.
Caspersen CS; Reznik B; Weldy PL; Abildskov KM; Stark RI; Garland M
Pharmacogenet Genomics; 2007 Jan; 17(1):11-24. PubMed ID: 17264799
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation in humans. Pharmacogenetic and developmental aspects.
de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
Clin Pharmacokinet; 1999 Jun; 36(6):439-52. PubMed ID: 10427468
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan.
Nagar S; Blanchard RL
Drug Metab Rev; 2006; 38(3):393-409. PubMed ID: 16877259
[TBL] [Abstract][Full Text] [Related]
13. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
[TBL] [Abstract][Full Text] [Related]
14. The novel UGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UDP-glucuronosyltransferase isozymes with a common carboxyl terminus.
Owens IS; Ritter JK; Yeatman MT; Chen F
J Pharmacokinet Biopharm; 1996 Oct; 24(5):491-508. PubMed ID: 9131487
[TBL] [Abstract][Full Text] [Related]
15. Uridine diphosphate glucuronosyltransferase 1A1.
Steventon G
Xenobiotica; 2020 Jan; 50(1):64-76. PubMed ID: 31092094
[TBL] [Abstract][Full Text] [Related]
16. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
Bosma PJ; Chowdhury JR; Bakker C; Gantla S; de Boer A; Oostra BA; Lindhout D; Tytgat GN; Jansen PL; Oude Elferink RP
N Engl J Med; 1995 Nov; 333(18):1171-5. PubMed ID: 7565971
[TBL] [Abstract][Full Text] [Related]
17. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
[TBL] [Abstract][Full Text] [Related]
18. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
[TBL] [Abstract][Full Text] [Related]
19. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency.
Sampietro M; Lupica L; Perrero L; Comino A; Martinez di Montemuros F; Cappellini MD; Fiorelli G
Br J Haematol; 1997 Nov; 99(2):437-9. PubMed ID: 9375769
[TBL] [Abstract][Full Text] [Related]
20. A new type of defect in the gene for bilirubin uridine 5'-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.
Aono S; Yamada Y; Keino H; Sasaoka Y; Nakagawa T; Onishi S; Mimura S; Koiwai O; Sato H
Pediatr Res; 1994 Jun; 35(6):629-32. PubMed ID: 7936809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
